Search

everythinglearnresearchcommunity

for

Search:↓

Patients with alopecia areata may have lower vitamin D levels than healthy people.

Higher IL-15 levels are linked to more severe hair loss in alopecia areata.

Stress can trigger or worsen alopecia areata.

Early onset, severe types, nail changes, family history, and body hair loss worsen alopecia areata prognosis; sticking to treatment helps.

Most men prefer keeping their eyebrows over scalp hair.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

Corticosteroids are the most common treatment for alopecia areata, but many patients need better options.

Scalp rolling might help regrow hair in people with a hair loss condition called Alopecia Areata.

Alopecia Areata significantly reduces quality of life, especially in women, long-term sufferers, and severe cases.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Alopecia Areata greatly affects the quality of life and mental health of Canadian patients and their caregivers.

Both platelet-rich plasma and low-level laser therapy effectively treat hair loss with minimal side effects and good cost-benefit ratio.

Alopecia areata mainly affects men aged 21-40 and is linked to autoimmune issues, thyroid problems, and inflammation.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Patients with alopecia areata prefer treatments that regrow scalp hair quickly over how often they need to take the medication.

Most kids with alopecia areata have other health issues, often allergies or skin conditions.

Tofacitinib effectively treats severe alopecia areata, improving hair regrowth and patient satisfaction.

Alopecia areata causes significant emotional distress, requiring treatments that focus on mental health and social support, not just hair regrowth.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Facial hair loss and psychosocial issues are crucial in deciding treatment for alopecia areata.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

Alopecia areata causes significant psychological distress in cancer patients, needing integrated care.

Negative illness perceptions increase emotional distress, worsening OCD symptoms in alopecia areata patients.

Hypnotherapy helps reduce or eliminate alopecia areata symptoms in children.

Hair loss significantly affects emotional and social well-being.

Hair loss significantly affects emotional and social well-being.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Alopecia areata is more common in males, mostly affects the scalp, and often appears as patchy hair loss.